Bg pattern

JORVEZA 1 mg ORALLY DISINTEGRATING TABLET

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

0.0 (0)
Doctor

Joao Silva

General medicine 6 years exp.

Dr. João Silva is a physician with training and experience in the field of General and Family Medicine, dedicated to providing healthcare focused on the well-being and quality of life of his patients. Throughout his professional career, he has developed broad clinical competencies, striving to maintain a medical practice based on scientific evidence and continuous knowledge updates.

Between 2013 and 2019, he completed the Integrated Master's Degree in Medicine at the Abel Salazar Institute of Biomedical Sciences in Porto, where he acquired a solid academic and clinical education.

Subsequently, between January 2021 and December 2021, he completed the General Internship at the Entre Douro e Vouga Hospital Center in Santa Maria da Feira, where he had the opportunity to work in different hospital settings and deepen his competencies in several areas of medicine.

From January 2022 until March 2026, he works as a Resident Physician in General and Family Medicine at USF Salvador Machado in Oliveira de Azeméis, developing clinical activities in primary healthcare, follow-up of chronic patients, and health promotion in the community.

Complementing his medical training, Dr. João Silva also completed a Postgraduate Degree in Continuing and Palliative Care at CESPU, strengthening his preparation in the comprehensive approach to patient care, especially in situations requiring prolonged care and multidisciplinary support.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use JORVEZA 1 mg ORALLY DISINTEGRATING TABLET

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the Patient

Jorveza 0.5 mg orodispersible tablets

Jorveza 1 mg orodispersible tablets

budesonide

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

Keep this leaflet. You may need to read it again.

  • Keep this leaflet, as you may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the pack

  1. What is Jorveza and what is it used for
  2. What you need to know before you take Jorveza
  3. How to take Jorveza
  4. Possible side effects
  5. Storage of Jorveza
  6. Contents of the pack and other information

1. What is Jorveza and what is it used for

Jorveza contains the active substance budesonide, a corticosteroid medicine that reduces inflammation.

It is used in adults (18 years and older) to treat eosinophilic oesophagitis, which is an inflammatory disorder of the oesophagus that causes problems with swallowing food.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you take Jorveza

Do not take Jorveza

  • if you are allergic to budesonide or any of the other ingredients of this medicine (listed in section 6).

Warnings and precautions

Tell your doctor or pharmacist before you start taking Jorveza if you have:

  • tuberculosis;
  • high blood pressure;
  • diabetes or if a member of your family has diabetes;
  • weakening of the bones (osteoporosis);
  • ulcers in the stomach or the first part of the small intestine (peptic ulcer);
  • increased pressure in the eye (which can cause glaucoma) or eye problems such as clouding of the lens (cataracts) or if a member of your family has glaucoma;
  • liver disease.

If you have any of the above conditions, you may have a higher risk of side effects. Your doctor will decide what measures to take and whether it is suitable for you to take this medicine.

Jorveza may cause the typical side effects of corticosteroid medicines and may affect all parts of the body, particularly if you take this medicine at high doses and for a long time (see section 4).

Additional precautions during treatment with Jorveza

  • Contact your doctor if you experience blurred vision or other vision problems.

Take the following precautions during treatment with Jorveza, as your immune system may be weakened:

  • Tell your doctor if you have fungal infections in the mouth, throat, and oesophagus or if you think you have an infection during treatment with this medicine. Symptoms of fungal infections may be white patches in the mouth and throat and difficulty swallowing. Symptoms of some infections may be unusual or less noticeable.
  • Stay away from people who have chickenpox or shingles (herpes zoster) if you have not had these infections. The effects of these diseases can be much worse during treatment with this medicine. If you come into contact with chickenpox or shingles, see your doctor immediately. Also, tell your doctor about your vaccination status.
  • Tell your doctor if you have not had measles and/or if and when you received your last vaccine for this disease.
  • If you need to receive any vaccine during treatment with this medicine, tell your doctor beforehand.
  • Tell your doctor that you are taking Jorveza in case of surgery.

Jorveza may affect the results of adrenal function tests (ACTH stimulation test) requested by your doctor or in a hospital. Tell your doctors that you have been taking Jorveza before any test is performed.

Children and adolescents

Jorveza must not be used in children and adolescents under 18 years of age. The use of this medicine in children under 18 years of age has not been studied yet.

Other medicines and Jorveza

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. Some of these medicines may increase the effects of Jorveza, so your doctor will monitor you closely if you are taking these medicines.

In particular:

  • ketoconazole or itraconazole (to treat fungal infections);
  • clarithromycin, an antibiotic used to treat infections;
  • ritonavir and cobicistat (to treat HIV infections);
  • oestrogens (used for hormone replacement therapy or contraception);
  • cardiac glycosides such as digoxin (medicines used to treat heart conditions);
  • diuretics (medicines used to treat excess fluid in your body).

Taking Jorveza with food and drinks

Do not drink grapefruit juice during treatment with this medicine, as it may worsen its side effects.

Pregnancy and breast-feeding

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.

Do not take this medicine during pregnancy without consulting your doctor first.

Do not take this medicine if you are breast-feeding unless you have discussed it with your doctor. Budesonide passes into breast milk in small amounts. Your doctor will help you decide whether to continue treatment and stop breast-feeding or to stop treatment during the period you are breast-feeding your baby.

Driving and using machines

Jorveza is unlikely to affect your ability to drive or use machines.

Jorveza contains sodium

This medicine contains 52 mg of sodium (main component of cooking/table salt) per daily dose. This is equivalent to 2.6% of the maximum recommended daily intake of sodium for an adult.

3. How to take Jorveza

Follow exactly the administration instructions of this medicine given by your doctor or pharmacist. If you are unsure, ask your doctor or pharmacist again.

The recommended dose for the treatment of acute episodes is two 1 mg orodispersible tablets (2 mg of budesonide) per day. Take one 1 mg orodispersible tablet in the morning and another 1 mg orodispersible tablet in the evening.

The recommended dose for the prevention of new episodes is two 0.5 mg orodispersible tablets (1 mg of budesonide) per day or two 1 mg orodispersible tablets (2 mg of budesonide) per day, depending on your body's response to treatment. Take one orodispersible tablet in the morning and another orodispersible tablet in the evening.

Method of administration

Take the orodispersible tablet immediately after removal from the blister pack.

Take the orodispersible tablet after a meal.

Place the orodispersible tablet on the tip of the tongue and close your mouth. Press it gently with your tongue against the palate until it has dissolved completely (this usually takes at least 2 minutes, but may take up to 20 minutes). Swallow the dissolved material slowly with saliva as the orodispersible tablet disintegrates.

DO NOTtake any liquid with the orodispersible tablet.

Do not chew or swallow the orodispersible tablet without dissolving.

Do not eat, drink, brush your teeth, or rinse your mouth for at least 30 minutes after taking the orodispersible tablet. Do not use any oral solution, spray, or chewable tablet for at least 30 minutes before or after administration of the orodispersible tablet. This will ensure the proper functioning of the medicine.

Kidney and liver problems

If you have any kidney or liver problems, tell your doctor. If you have kidney problems, your doctor will decide whether Jorveza is suitable for you. If your kidney problems are severe, you must not take Jorveza. If you have liver disease, you must not take Jorveza.

Duration of treatment

Initially, your treatment should last approximately 6 to 12 weeks.

After treatment of the acute episode, your doctor will decide how long and at what dose you should continue treatment, depending on your condition and response to treatment.

If you take more Jorveza than you should

If you have taken too many orodispersible tablets at once, just take the prescribed dose at the next scheduled time. Do not take a lower dose. If you are unsure, contact your doctor. If possible, take the pack and this leaflet with you.

If you forget to take Jorveza

If you miss a dose, take the next dose at the usual time. Do not take a double dose to make up for forgotten doses.

If you stop taking Jorveza

Talk to your doctor if you want to stop or conclude your treatment prematurely. It is important that you do not stop taking your medicine without talking to your doctor. Continue taking your medicine until your doctor tells you to stop, even if you feel better.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

The following side effects have been reported during use of Jorveza:

Very common: may affect more than 1 in 10 people

  • Fungal infections in the oesophagus (which can cause pain or discomfort when swallowing).

Common: may affect up to 1 in 10 people

  • Headache.
    • Fungal infections in the mouth and throat (whose symptoms can be white patches).
    • Heartburn.
    • Indigestion.
    • Feeling sick (nausea).
    • Tingling or numbness of the mouth.
    • Fatigue.
    • Decreased amount of cortisol hormone in the blood.

Uncommon: may affect up to 1 in 100 people

  • Difficulty sleeping.
  • Anxiety.
  • Dizziness.
  • Taste disturbance.
  • Dry eyes.
  • High blood pressure.
  • Cough, dry throat.
  • Abdominal pain, pain in the upper abdomen.
  • Difficulty swallowing.
  • Inflammation of the stomach, stomach ulcers.
  • Tongue burning, lip swelling, dry mouth.
  • Rash, itchy rash.
  • Feeling of a foreign body.
  • Pain in the mouth or throat.

The following side effects have been reported with similar medicines to Jorveza (corticosteroids), so they may also occur with this medicine. The frequency of these events is currently unknown:

  • Increased risk of infection.
  • Cushing's syndrome, which is associated with excessive use of corticosteroids and causes roundness of the face (moon face), weight gain, increased blood sugar, fluid accumulation in tissues (e.g. swollen legs), decreased potassium levels in the blood (hypokalaemia), irregular menstrual periods in women, unwanted hair growth in women, impotence, stretch marks on the skin, acne.
  • Delayed growth in children.
  • Mood changes, such as depression, irritation, or euphoria.
  • Restlessness with increased physical activity, anxiety, aggression.
  • Increased intracranial pressure, possibly with increased eye pressure (inflammation of the optic disc) in adolescents.
  • Blurred vision.
  • Increased risk of blood clots, inflammation of blood vessels (which can occur when the medicine is stopped after long-term use).
  • Constipation, ulcers in the small intestine.
  • Pancreatitis, which causes severe abdominal and back pain.
  • Rash, red spots due to bleeding in the skin, delayed wound healing, skin reactions such as contact dermatitis, bruising.
  • Muscle and joint pain, muscle weakness, muscle spasms.
  • Weakening of the bones (osteoporosis), bone damage due to poor blood circulation (osteonecrosis).
  • Feeling unwell.

Reporting of side effects

If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Jorveza

Keep this medicine out of the sight and reach of children.

Do not take this medicine after the expiry date which is stated on the carton and blister after “EXP”. The expiry date is the last day of the month shown.

Do not store above 25°C. Store in the original package to protect from light and moisture.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.

6. Contents of the pack and other information

Composition of Jorveza

Jorveza 0.5 mg orodispersible tablet

  • The active substance is budesonide. Each orodispersible tablet contains 0.5 mg of budesonide.
  • The other ingredients are sodium citrate, sodium docusate, macrogol (6000), magnesium stearate, mannitol (E 421), anhydrous sodium citrate, povidone (K25), sodium hydrogen carbonate, and sucralose (see also section 2, “Jorveza contains sodium”).

Jorveza 1 mg orodispersible tablet

  • The active substance is budesonide. Each orodispersible tablet contains 1 mg of budesonide.
  • The other ingredients are sodium citrate, sodium docusate, macrogol (6000), magnesium stearate, mannitol (E 421), anhydrous sodium citrate, povidone (K25), sodium hydrogen carbonate, and sucralose (see also section 2, “Jorveza contains sodium”).

Appearance and packaging

Jorveza 0.5 mg orodispersible tablet

Jorveza 0.5 mg orodispersible tablets are white, round, and biplanar. They are engraved with “0.5” on one side. They are available in blisters of 20, 60, 90, 100, or 200 orodispersible tablets.

Jorveza 1 mg orodispersible tablet

Jorveza 1 mg orodispersible tablets are white, round, and biplanar. They are available in blisters of 20, 30, 60, 90, 100, or 200 orodispersible tablets.

Not all pack sizes may be marketed.

Marketing authorisation holder and manufacturer

Dr. Falk Pharma GmbH

Leinenweberstr. 5

79108 Freiburg

Germany

You can request more information about this medicine from the local representative of the marketing authorisation holder:

Spain

Dr. Falk Pharma España

Tel: +34 91 372 95 08

[email protected]

Date of last revision of this leaflet:{MM/AAAA}.

Detailed information on this medicine is available on the European Medicines Agency website: http://www.ema.europa.eu.

Online doctors for JORVEZA 1 mg ORALLY DISINTEGRATING TABLET

Discuss questions about JORVEZA 1 mg ORALLY DISINTEGRATING TABLET, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

0.0 (0)
Doctor

Hocine Lokchiri

General medicine 21 years exp.

Dr. Hocine Lokchiri is a French consultant with over 20 years of experience in General and Emergency Medicine. He works with adults and children, helping patients with urgent symptoms, infections, sudden health changes and everyday medical concerns that require timely evaluation. His background includes clinical practice in France, Switzerland and the United Arab Emirates, which allows him to navigate different healthcare systems and manage a wide range of conditions with confidence. Patients value his calm, structured approach, clear explanations and evidence-based decision-making.

Online consultations with Dr. Lokchiri are suitable for many situations when someone needs quick medical guidance, reassurance or a clear next step. Common reasons for booking include:

  • fever, chills, fatigue and viral symptoms
  • cough, sore throat, nasal congestion, breathing discomfort
  • bronchitis and mild asthma flare-ups
  • nausea, diarrhoea, abdominal pain, digestive infections
  • rashes, allergic reactions, redness, insect bites
  • muscle or joint pain, mild injuries, sprains
  • headache, dizziness, migraine symptoms
  • stress-related symptoms, sleep disturbances
  • questions about test results and treatment plans
  • management of chronic conditions in stable phases
Many patients reach out when symptoms appear suddenly and cause concern, when a child becomes unwell unexpectedly, when a rash changes or spreads, or when it’s unclear whether an in-person examination is necessary. His emergency medicine background is particularly valuable online, helping patients understand risk levels, identify warning signs and choose safe next steps.

Some situations are not suitable for online care. If a patient has loss of consciousness, severe chest pain, uncontrolled bleeding, seizures, major trauma or symptoms suggesting a stroke or heart attack, he will advise seeking immediate local emergency services. This improves safety and ensures patients receive the right level of care.

Dr. Lokchiri’s professional training includes:

  • Advanced Trauma Life Support (ATLS)
  • Basic and Advanced Cardiac Life Support (BLS/ACLS)
  • Pediatric Advanced Life Support (PALS)
  • Prehospital Trauma Life Support (PHTLS)
  • eFAST and critical care transthoracic echocardiography
  • aviation medicine
He is an active member of several professional organisations, including the French Society of Emergency Medicine (SFMU), the French Association for Emergency Physicians (AMUF) and the Swiss Society of Emergency and Rescue Medicine (SGNOR). In consultations, he works with clarity and precision, helping patients understand their symptoms, possible risks and the safest treatment options.
0.0 (11)
Doctor

Rita Isabel Calero Garcia

General medicine 2 years exp.

Dr. Rita Isabel Calero Garcia is a physician with extensive experience in emergency medical care, general medicine, and healthcare assistance in various clinical and out-of-hospital settings.

She currently works as a physician at the Canary Islands Emergency Service (Servicio de Urgencias Canario – SUC), where she is responsible for the assessment and care of patients in medical emergency situations, performing the initial diagnosis, patient stabilization, and coordination with hospital services when necessary.

She has also developed her professional activity within the Primary Care Management Service, providing consultations in general medicine. In this setting she is responsible for patient follow-up, management of acute and chronic conditions, as well as health promotion and disease prevention.

She has also worked as a physician in a mobile ICU unit, providing medical assistance in out-of-hospital emergencies, treating critical patients and participating in medicalized patient transport.

In addition, she has collaborated with the Red Cross, participating in healthcare support units, providing medical assistance at events and supporting emergency interventions.

Furthermore, she has provided medical services in the private sector with Salvaser, conducting clinical assessments of patients and providing healthcare services within private medical services.

0.0 (0)
Doctor

Joao Silva

General medicine 6 years exp.

Dr. João Silva is a physician with training and experience in the field of General and Family Medicine, dedicated to providing healthcare focused on the well-being and quality of life of his patients. Throughout his professional career, he has developed broad clinical competencies, striving to maintain a medical practice based on scientific evidence and continuous knowledge updates.

Between 2013 and 2019, he completed the Integrated Master's Degree in Medicine at the Abel Salazar Institute of Biomedical Sciences in Porto, where he acquired a solid academic and clinical education.

Subsequently, between January 2021 and December 2021, he completed the General Internship at the Entre Douro e Vouga Hospital Center in Santa Maria da Feira, where he had the opportunity to work in different hospital settings and deepen his competencies in several areas of medicine.

From January 2022 until March 2026, he works as a Resident Physician in General and Family Medicine at USF Salvador Machado in Oliveira de Azeméis, developing clinical activities in primary healthcare, follow-up of chronic patients, and health promotion in the community.

Complementing his medical training, Dr. João Silva also completed a Postgraduate Degree in Continuing and Palliative Care at CESPU, strengthening his preparation in the comprehensive approach to patient care, especially in situations requiring prolonged care and multidisciplinary support.

5.0 (53)
Doctor

Anna Biriukova

General medicine 6 years exp.

Dr Anna Biriukova is an internal medicine doctor with clinical experience in cardiology, endocrinology, and gastroenterology. She provides online consultations for adults, offering expert medical support for heart health, hormonal balance, digestive issues, and general internal medicine.

Cardiology – Diagnosis and treatment of:

  • High blood pressure, blood pressure fluctuations, and cardiovascular risk prevention.
  • Chest pain, shortness of breath, arrhythmias (tachycardia, bradycardia, palpitations).
  • Leg swelling, chronic fatigue, reduced exercise tolerance.
  • EKG interpretation, lipid profile evaluation, cardiovascular risk assessment (heart attack, stroke).
  • Post-COVID-19 cardiac monitoring and care.
Endocrinology – Diabetes, thyroid, metabolism:
  • Diagnosis and management of type 1 and type 2 diabetes, and prediabetes.
  • Individual treatment plans including oral medications and insulin therapy.
  • GLP-1 therapy– modern pharmacological treatment for weight management and diabetes control, including drug selection, monitoring, and safety follow-up.
  • Thyroid disorders – hypothyroidism, hyperthyroidism, autoimmune thyroid diseases (Hashimoto’s, Graves’ disease).
  • Metabolic syndrome – obesity, lipid disorders, insulin resistance.
Gastroenterology – Digestive health:
  • Abdominal pain, nausea, heartburn, gastroesophageal reflux (GERD).
  • Stomach and intestinal conditions: gastritis, irritable bowel syndrome (IBS), indigestion.
  • Management of chronic digestive disorders and interpretation of tests (endoscopy, ultrasound, labs).
General internal medicine and preventive care:
  • Respiratory infections – cough, colds, bronchitis.
  • Lab test analysis, therapy adjustments, medication management.
  • Adult vaccinations – planning, contraindications assessment.
  • Cancer prevention – screening strategies and risk assessment.
  • Holistic approach – symptom relief, complication prevention, and quality of life improvement.
Dr Biriukova combines internal medicine with specialist insight, offering clear explanations, personalised treatment plans, and comprehensive care tailored to each patient.
0.0 (15)
Doctor

Antonio Cayatte

General medicine 44 years exp.

Dr Antonio Cayatte is a physician in General and Acute Medicine with over 30 years of experience across clinical care, medical research, and education. He offers online consultations for adults with a wide range of symptoms, both acute and chronic. His clinical background includes: 

  • assessment of sudden or unclear symptoms
  • ongoing care for chronic conditions
  • follow-up after hospital discharge
  • interpretation of test results
  • medical support while abroad

Dr Cayatte earned his degree from the University of Lisbon and taught internal medicine at Boston University School of Medicine. He holds active medical registrations in both Portugal and the UK and is a Fellow of the American Heart Association. Consultations are available in English and Portuguese. Patients value his clarity, professionalism, and balanced approach to evidence-based care.

Dr. Antonio Cayatte provides comprehensive care for a broad spectrum of common health concerns, including:

  • Respiratory & ENT: acute bronchitis, concerns related to pneumonia, sinusitis, tonsillitis, ear infections, sore throat conditions, and allergic rhinitis
  • Eye Health: allergic and infectious conjunctivitis, as well as red or irritated eyes
  • Digestive & Urinary: gastroesophageal reflux disease (GERD), gastritis, urinary tract infections, and cystitis
  • Chronic Conditions: hypertension, elevated cholesterol, and structured weight management planning
0.0 (0)
Doctor

Sviatoslav Chekhun

Oncology 13 years exp.

Dr. Sviatoslav Chekhun is a medical oncologist with international clinical and research experience, specializing in modern medical oncology and a personalized approach to cancer treatment.

Currently (since 2025), he works as a Medical Oncologist at Institut Català d’Oncologia (Girona, Spain). Previously, he completed his residency in Medical Oncology and was involved in clinical research at Hospital Universitari Germans Trias i Pujol.

Dr. Chekhun has a strong academic and scientific background. He served as a lecturer in Internal Medicine at O.O. Bohomolets National Medical University and conducted research in experimental oncology at the R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology.

Earlier in his career, he worked as a medical oncologist at the Kyiv City Clinical Oncological Center and contributed to regulatory evaluation of medicinal products at the State Expert Center of the Ministry of Health of Ukraine.

When to consult Dr. Chekhun:

  •  for diagnosis or clarification of a cancer diagnosis
  •  to obtain a second opinion on an existing treatment plan 
  •  when you need a personalized treatment strategy 
  •  for interpretation of test results, CT, MRI, PET-CT, and biopsies 
  •  when choosing between treatment options (chemotherapy, targeted therapy, immunotherapy) 
  •  in case of doubts about treatment strategy or disease progression 

Consultation format

Dr. Chekhun provides online consultations, where you can receive:

  •  expert second opinion 
  •  detailed case review 
  •  recommendations based on current international treatment guidelines 
  •  personalized treatment and follow-up plan 

Important:
Prescription and monitoring of medications must be carried out by your treating physician in an in-person (offline) setting. An online consultation does not replace a face-to-face visit but helps you make more informed decisions about your treatment.

Dr. Sviatoslav Chekhun combines clinical practice, research, and international experience, enabling him to provide patients with modern, evidence-based approaches in oncology.

Get JORVEZA 1 mg ORALLY DISINTEGRATING TABLET Prescription Online

1

Fill in a 2-min form

Tell us your symptoms, history, and what medicine you're requesting.

2

Pick a doctor or let us assign

Choose a specialist or we'll match you with the next available doctor.

3

Doctor reviews your case

Usually within 30 minutes. They may ask follow-up questions via chat.

4

Collect from any pharmacy

Electronic prescription sent to your email — valid across Spain.

Frequently Asked Questions

Is a prescription required for JORVEZA 1 mg ORALLY DISINTEGRATING TABLET?

JORVEZA 1 mg ORALLY DISINTEGRATING TABLET requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.

What is the active substance in JORVEZA 1 mg ORALLY DISINTEGRATING TABLET?

The active ingredient in JORVEZA 1 mg ORALLY DISINTEGRATING TABLET is budesonide. This information helps identify medicines with the same composition but different brand names.

Who manufactures JORVEZA 1 mg ORALLY DISINTEGRATING TABLET?

JORVEZA 1 mg ORALLY DISINTEGRATING TABLET is manufactured by Dr. Falk Pharma Gmbh. Pharmacy brands and packaging may differ depending on the distributor.

Which doctors can assess the use of JORVEZA 1 mg ORALLY DISINTEGRATING TABLET online?

Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether JORVEZA 1 mg ORALLY DISINTEGRATING TABLET is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.

How to buy JORVEZA 1 mg ORALLY DISINTEGRATING TABLET in Spain?

Spain has a well-developed healthcare infrastructure across major cities such as Madrid, Barcelona, Valencia, and Seville. Pharmacies are widely available and operate under strict regulations, ensuring access to prescribed medications.

You can buy JORVEZA 1 mg ORALLY DISINTEGRATING TABLET in Madrid, Barcelona, Seville, or Valencia at any local pharmacy with a valid prescription.

To obtain a prescription, you can use Oladoctor:

What are the alternatives to JORVEZA 1 mg ORALLY DISINTEGRATING TABLET?

Other medicines with the same active substance (budesonide) include ENTOCORD 2 mg TABLETS AND SOLUTION FOR RECTAL SUSPENSION, ENTOCORD 3 mg MODIFIED-RELEASE CAPSULES, INTESTIFALK 2 mg/DOSE RECTAL FOAM. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.

bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media